Onyx Healthcare Inc. (TPEX:6569)
Taiwan · Delayed Price · Currency is TWD 96.10
+2.20 (2.34%)
At close: Mar 6, 2026
Onyx Healthcare Market Cap
Onyx Healthcare has a market cap or net worth of 3.75 billion as of March 6, 2026. Its market cap has decreased by -44.60% in one year.
Market Cap
3.75B
Enterprise Value
3.67B
Revenue
1.31B
Ranking
n/a
PE Ratio
33.48
Stock Price
96.10
Market Cap Chart
Since January 15, 2016, Onyx Healthcare's market cap has increased from 1.94B to 3.75B, an increase of 93.89%. That is a compound annual growth rate of 6.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.75B | -12.24% |
| Dec 31, 2025 | 4.28B | -27.59% |
| Dec 31, 2024 | 5.91B | 2.52% |
| Dec 29, 2023 | 5.76B | 77.16% |
| Dec 30, 2022 | 3.25B | 2.87% |
| Dec 30, 2021 | 3.16B | -11.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 248.68B |
| Caliway Biopharmaceuticals | 217.00B |
| Heron Neutron Medical | 73.55B |
| Lotus Pharmaceutical | 67.06B |
| Genovate Biotechnology | 3.73B |
| ACRO Biomedical | 3.73B |
| Bionime | 3.73B |
| Intech Biopharm | 3.71B |